Jonathan P. Mow - Aug 27, 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
Chief Executive Officer, Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
Aug 27, 2021
Transactions value $
$24,800
Form type
4
Date filed
8/30/2021, 05:52 PM
Previous filing
May 24, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise $24.8K +20K +15.77% $1.24* 147K Aug 27, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Employee Stock Option (right to buy) Options Exercise $0 -20K -13.44% $0.00 129K Aug 27, 2021 Common Stock 20K $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.